Literature DB >> 23486085

miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.

Ming Zhong1, Zhengqian Bian, Zhiyong Wu.   

Abstract

BACKGROUND/AIMS: MicroRNAs (miRNAs) play key roles in tumor metastasis. The aim of this study was to determine the regulation and function of miR-30a in colorectal carcinoma (CRC) metastasis.
METHODS: The expression of miR-30a was detected in CRC cell lines and samples by qRT-PCR. The anti-metastatic effect of miR-30a was determined by both in vitro and in vivo assays. A luciferase reporter assay was performed to determine target association between miR-30a and phosphoinositide 3-kinase catalytic subunit delta (PIK3CD).
RESULTS: miR-30a was significantly downregulated in highly metastatic CRC cell lines and metastatic tissues. Overexpression of miR-30a suppressed CRC cell migration and invasion in vitro and liver metastasis in vivo, whereas miR-30a deletion dramatically promoted cell migration and invasion. Further studies revealed that PIK3CD is a direct target of miR-30a as miR-30a bounds directly to the 3'-UTR of PIK3CD, subsequently reducing its expression. Similar to the restoring miR-30a expression, PIK3CD downregulation inhibited cell migration and invasion, whereas PIK3CD overexpression rescued the suppressive effect of miR-30a. Moreover, significant downregulation of miR-30a in metastatic CRC tissues was found to be inversely correlated with PIK3CD expression. Mechanistic studies revealed that miR-30a down-regulated the expression of key components of the Akt/mTOR pathway, whereas PIK3CD overexpression reversed this negative effect.
CONCLUSION: Our findings indicate that miR-30a might function as a metastasis suppressor in CRC. miR-30a may be a potential therapeutic target to block CRC metastasis.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486085     DOI: 10.1159/000343362

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  49 in total

1.  MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells.

Authors:  Jianguo Hu; Ying Meng; Zhanqin Zhang; Qiuting Yan; Xingwei Jiang; Zilan Lv; Lina Hu
Journal:  Autophagy       Date:  2016-11-22       Impact factor: 16.016

2.  The role of DNA methylation in human trophoblast differentiation.

Authors:  Teena K J B Gamage; William Schierding; Daniel Hurley; Peter Tsai; Jackie L Ludgate; Chandrakanth Bhoothpur; Lawrence W Chamley; Robert J Weeks; Erin C Macaulay; Joanna L James
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

Review 3.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

4.  Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.

Authors:  Qian Zhang; Qingchao Tang; Dandan Qin; Lei Yu; Rui Huang; Guixiang Lv; Zhaoxia Zou; Xiao-chen Jiang; Chendan Zou; Wei Liu; Jing Luo; Zhixun Zhao; Shan Muhammad; Guiyu Wang; Ying-gang Chen; Xishan Wang
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

5.  Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.

Authors:  Ming Zhao; Dingya Sun; Yangtai Guan; Zhihong Wang; Daoqian Sang; Mingdong Liu; Yingyan Pu; Xue Fang; Dan Wang; Aijun Huang; Xiaoying Bi; Li Cao; Cheng He
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

6.  miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.

Authors:  Hui Zhou; Changwei Lin; Yi Zhang; Xiuzhong Zhang; Chong Zhang; Pengbo Zhang; Xingwang Xie; Zeqiang Ren
Journal:  Cell Prolif       Date:  2017-02-19       Impact factor: 6.831

7.  Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.

Authors:  M C Crank; J K Grossman; S Moir; S Pittaluga; C M Buckner; L Kardava; A Agharahimi; H Meuwissen; J Stoddard; J Niemela; H Kuehn; S D Rosenzweig
Journal:  J Clin Immunol       Date:  2014-03-08       Impact factor: 8.317

8.  MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.

Authors:  Y R Park; S L Kim; M R Lee; S Y Seo; J H Lee; S H Kim; I H Kim; S O Lee; S T Lee; Sang Wook Kim
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-20       Impact factor: 4.553

9.  Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy.

Authors:  Peng Wang; Jia Liang; Yun Li; Jiefei Li; Xuan Yang; Xinxin Zhang; Song Han; Shujuan Li; Junfa Li
Journal:  Neurochem Res       Date:  2014-04-26       Impact factor: 3.996

10.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Authors:  Myriem Boufraqech; Naris Nilubol; Lisa Zhang; Sudheer Kumar Gara; Samira M Sadowski; Amit Mehta; Mei He; Sean Davis; Jennifer Dreiling; John A Copland; Robert C Smallridge; Martha M Quezado; Electron Kebebew
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.